Q5106 Injection retacrit non-esrd use
Also known as: Retacrit injection non-ESRD, epoetin alfa-epbx
Injection of Retacrit, epoetin alfa-epbx biosimilar for non-end-stage renal disease use, per unit.
In Plain Language
red blood cell booster; anemia management
Clinical Context
Used for chemotherapy-induced anemia and other non-dialysis anemia conditions.
RVU Information
CPT Q5106 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5106?
CPT Q5106 (Injection retacrit non-esrd use) is a Q Codes code. Injection of Retacrit, epoetin alfa-epbx biosimilar for non-end-stage renal disease use, per unit.
Is Q5106 covered by insurance?
Q5106 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-induced anemia and other non-dialysis anemia conditions.
When is CPT Q5106 used?
Used for chemotherapy-induced anemia and other non-dialysis anemia conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.